A decade ago, Cindy Eckert struggled to convince skeptics about a drug for premenopausal women. Lately, her business is booming.Cindy Eckert, the chief executive of Sprout, the company behind Addyi, a prescription drug that treats hypoactive sexual desire disorder, or H.S.D.D.
A Pill for Women’s Libido Meets a Cultural Moment
Scritto il 16/11/2025